Epidermal growth factor therapy and wound healing - past, present and future

Hardwicke, Joseph, Schmaljohann, D., Boyce, D. and Thomas, David William ORCID: https://orcid.org/0000-0001-7319-5820 2008. Epidermal growth factor therapy and wound healing - past, present and future. Surgeon-Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 6 (3) , pp. 172-177. 10.1016/S1479-666X(08)80114-X

Full text not available from this repository.

Abstract

The role of epidermal growth factor (EGF) has been extensively investigated in normal and pathological wound healing. It is implicated in keratinocyte migration, fibroblast function and the formation of granulation tissue. Since the discovery of EGF, the first growth factor to be isolated, over 45 years ago, growth factor therapy has progressed into clinical practice in the treatment of wounds. The investigation EGF in wound healing has progressed from the treatment of acute wounds, to its limited effect in chronic wounds. EGF is readily degraded in the chronic wound environment, but with the recent focus of research in new drug delivery systems that are able to protect and stabilise the protein, the potential healing effects of EGF are at the forefront of research. In this review, the history of EGF and wound healing research is considered, as are current and future therapeutic options.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Dentistry Systems Immunity Research Institute (SIURI)
Publisher:	Elsevier
ISSN:	1479-666X
Last Modified:	18 Oct 2022 13:55
URI:	https://orca.cardiff.ac.uk/id/eprint/15880

Citation Data

Cited 185 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item